Danuglipron is a small-molecule GLP-1 receptor agonist that was under development as an oral pharmaceutical compound. It has been investigated for its effects on weight reduction and glycemic control, with nausea, diarrhea, and vomiting reported as common adverse events.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2230198-02-2
3-Methylclobazam
pharmaceutical impurity standard
Clobazam impurity A CRS
pharmaceutical impurity reference standard
Clobazam
active pharmaceutical ingredient
N-Desmethylclobazam
active pharmaceutical metabolite
2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic acid
HYBAKUMPISVZQP-DEOSSOPVSA-N
C1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F